Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies

Parkinson’s disease (PD) and multiple system atrophy are types of adult-onset neurodegenerative disorders named synucleinopathies, which are characterized by prominent intracellular α-synuclein (αSyn) aggregates. We have previously found that αSyn aggregates and the vulnerability of dopaminergic neu...

Full description

Bibliographic Details
Main Authors:	Hideki Oizumi, Kenshi Yamasaki, Hiroyoshi Suzuki, Takafumi Hasegawa, Yoko Sugimura, Toru Baba, Kohji Fukunaga, Atsushi Takeda
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Aging Neuroscience
Subjects:	α-synuclein multiple system atrophy fatty acid-binding protein human Parkinson’s disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.648982/full

Similar Items

Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
by: Konno Masatoshi, et al.
Published: (2012-08-01)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
by: An Cheng, et al.
Published: (2021-05-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
by: Tritia R. Yamasaki, et al.
Published: (2020-05-01)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
by: Violetta Refolo, et al.
Published: (2019-06-01)

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
by: Marie-Laure Arotcarena, et al.
Published: (2019-06-01)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
by: Antonio Heras-Garvin, et al.
Published: (2020-01-01)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
by: Miguel Lemos, et al.
Published: (2020-09-01)

Calcium: alpha-synuclein interactions in alpha-synucleinopathies
by: Alexandre N. Rcom-H’cheo-Gauthier1, et al.
Published: (2016-12-01)

Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing
by: Diego Perez-Rodriguez, et al.
Published: (2019-12-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Phytochemicals as Regulators of Genes Involved in Synucleinopathies
by: Andrei Surguchov, et al.
Published: (2021-04-01)

Étude moléculaire de la propagation de l’agrégation de l’alpha-synucléine dans un modèle transgénique de la maladie de Parkinson : impact de la surexpression de la beta-synucléine à l’aide de vecteurs viraux adéno-associés (AAV)
by: Sargent, Dorian
Published: (2018)

Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits
by: Wouter Peelaerts, et al.
Published: (2020-11-01)

Multiple system atrophy: A prototypical synucleinopathy for disease-modifying therapeutic strategies
by: Pierre-Olivier Fernagut, et al.
Published: (2014-07-01)

Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies
by: Tomasz Brudek, et al.
Published: (2017-06-01)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
by: Irina Alecu, et al.
Published: (2019-04-01)

Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons
by: Emily M. Rocha, et al.
Published: (2015-10-01)

Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies
by: Takehiro Nakagaki, et al.
Published: (2021-09-01)

Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies
by: Ethan W. Hass, et al.
Published: (2021-08-01)

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
by: Naomi P. Visanji, et al.
Published: (2019-09-01)

Enteric synucleinopathy: real entity or only a trendy concept?
by: Adrien de Guilhem de Lataillade, et al.
Published: (2020-08-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
by: Emanuela Colla
Published: (2019-05-01)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
by: Ichiro Kawahata, et al.
Published: (2020-05-01)

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury Under Oxidative Stress
by: Yifei Wang, et al.
Published: (2021-01-01)

Seeding and structural varibility in α-synucleinopathies
by: Candelise, Niccolò
Published: (2019)

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
by: Yasushi Yabuki, et al.
Published: (2020-03-01)

The interplay between α-synuclein and Rab GTPases: Insights into the molecular basis of synucleinopathies
by: Eisbach, Sibylle Elisabeth
Published: (2015)

Chronic Caffeine Treatment Protects Against α-Synucleinopathy by Reestablishing Autophagy Activity in the Mouse Striatum
by: Yanan Luan, et al.
Published: (2018-05-01)

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
by: Joseph R. Patterson, et al.
Published: (2019-10-01)

Impact moléculaire de l’exposition subchronique par voie orale à un pesticide, le paraquat, dans un modèle murin transgénique de synucléinopathie humaine : implication du système nerveux entérique
by: Naudet, Nicolas
Published: (2017)

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP<sup>+</sup>-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons
by: Ichiro Kawahata, et al.
Published: (2019-10-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease
by: Emiko Miura, et al.
Published: (2014-11-01)

A Novel Microfluidic Cell Co-Culture Platform for the Study of the Molecular Mechanisms of Parkinson’s Disease and other Synucleinopathies
by: João Tiago Fernandes, et al.
Published: (2016-11-01)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
by: Lijun Dai, et al.
Published: (2021-07-01)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)